doxorubicin hydrochloride has been researched along with dcb 3503 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Han, G; Liu, Y; Meng, C; Meng, LH; Qing, L; Shi, J; Wang, Q; Wang, Y; Wang, Z; Yang, Y | 1 |
| Ding, J; Han, G; Liu, X; Liu, Y; Meng, LH; Qing, L; Wang, Q; Wang, Y; Wang, Z; Wu, M | 1 |
2 other study(ies) available for doxorubicin hydrochloride and dcb 3503
| Article | Year |
|---|---|
6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Neoplasms; Phenanthrolines; Quinolizines; S Phase | 2017 |
Design, synthesis, and biological activity evaluation of (-)-6-O-desmethylantofine analogues as potent anti-cancer agents.
Topics: Antineoplastic Agents; Humans; Structure-Activity Relationship | 2019 |